Medical XpressNew immunotherapy for lung cancer shows promise of successMedical XpressIn a clinical trial, Mark Rubinstein, Ph.D., (left) and John Wrangle, M.D., used two drugs that have never been combined in humans before to slow the progression of l… Continue reading
Medical XpressNew immunotherapy for lung cancer shows promise of successMedical XpressIn a clinical trial, Mark Rubinstein, Ph.D., (left) and John Wrangle, M.D., used two drugs that have never been combined in humans before to slow the progression of l… Continue reading
Sheridan Media (press release)Synthetic, 3D-printed Meat Subject of Talk at UWSheridan Media (press release)Synthetic biology meats and 3D-printed meat were the focus of a talk by Jim Kinder at the University of Wyoming recently. Kinder, from Ohio Stat… Continue reading
Dr. Nanus Discusses Immunotherapy in Kidney CancerOncLiveImmunotherapy is a promising therapy for patients with kidney cancer, says Nanus. There are preliminary results from many studies that show exciting results. The use of immunotherapy has a lot of… Continue reading
OncLiveDr. Nanus Discusses Immunotherapy in Kidney CancerOncLiveImmunotherapy is a promising therapy for patients with kidney cancer, says Nanus. There are preliminary results from many studies that show exciting results. The use of immunotherapy has a… Continue reading
OncLiveDr. Nanus Discusses Immunotherapy in Kidney CancerOncLiveImmunotherapy is a promising therapy for patients with kidney cancer, says Nanus. There are preliminary results from many studies that show exciting results. The use of immunotherapy has a… Continue reading
Macrogen Licenses Broad Institute CRISPR TechnologyGenomeWebMacrogen Licenses Broad Institute CRISPR Technology. Apr 05, 2018. |. staff reporter. NEW YORK (GenomeWeb) – South Korean genomic services provider Macrogen announced today that it has acquire… Continue reading
|
‘Sleeping’ Stem Cells could Aid Brain Repair – Scicasts
Scicasts (press release) (blog) Research into Stem Cells has grown exponentially over the past two decades and has already yielded successful or promising therapies for a number of diseases. This Channel is a collection of the most exciting developments in stem cell genetics and … |